id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
dpc-2121	Nogueira, Miguel; Torres, Tiago	Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis: Focus on Abrocitinib, Baricitinib, and Upadacitinib	2021	9	.pdf	application/pdf	6235	407	59	The knowledge acquired over the last decade on AD pathophysiology and disease burden led to the development of new targeted therapeutic op- tions that enable clinicians to better manage AD patients. 2021;11(4):e2021145 3 In the following review, we will focus on the results of the available phase III clinical trials of oral JAK inhibitors used in AD patients after their positive data on safety and efficacy in phase I and II studies, namely baricitinib, upadacitinib and abrocitinib (Table 1).	cache/dpc-2121.pdf	txt/dpc-2121.txt